Dendritic Cell Functions Regulatory Activity of Autocrine IL-10 on
暂无分享,去创建一个
Giampiero Girolomoni | Silvia Corinti | Cristina Albanesi | C. Albanesi | G. Girolomoni | S. Corinti
[1] Susan D. Spencer,et al. The Orphan Receptor CRF2-4 Is an Essential Subunit of the Interleukin 10 Receptor , 1998, The Journal of experimental medicine.
[2] M. Mayo,et al. Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. , 1999, The Journal of biological chemistry.
[3] V. Verhasselt,et al. Interleukin‐10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin‐4 and granulocyte/ macrophage‐colony‐stimulating factor , 1997, European journal of immunology.
[4] S. Akira,et al. Interleukin-10 Receptor Signaling through the JAK-STAT Pathway , 1999, The Journal of Biological Chemistry.
[5] A. Enk,et al. Induction of hapten-specific tolerance by interleukin 10 in vivo , 1994, The Journal of experimental medicine.
[6] A. Sher,et al. The role of dendritic cells in the induction and regulation of immunity to microbial infection. , 1999, Current opinion in immunology.
[7] R. Steinman,et al. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro , 1985, The Journal of experimental medicine.
[8] R. Steinman,et al. Trance, a Tumor Necrosis Factor Family Member, Enhances the Longevity and Adjuvant Properties of Dendritic Cells in Vivo , 2000, The Journal of experimental medicine.
[9] C Caux,et al. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. , 1998, Journal of immunology.
[10] P. Allavena,et al. IL‐10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages , 1998, European journal of immunology.
[11] Jonathan M. Austyn,et al. Dendritic cells , 1998, Current opinion in hematology.
[12] R. de Waal Malefyt,et al. Expression cloning and characterization of a human IL-10 receptor. , 1994, Journal of immunology.
[13] R. Offringa,et al. Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10. , 2000, Blood.
[14] Joanna M. Roberts,et al. CD8+ T Cell-Dependent Elimination of Dendritic Cells In Vivo Limits the Induction of Antitumor Immunity1 , 2000, The Journal of Immunology.
[15] D. Douek,et al. Split activity of interleukin‐10 on antigen capture and antigen presentation by human dendritic cells: Definition of a maturative step , 1997, European journal of immunology.
[16] A. Enk,et al. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. , 1999, Blood.
[17] P. Ricciardi-Castagnoli,et al. Human dendritic cells very efficiently present a heterologous antigen expressed on the surface of recombinant gram-positive bacteria to CD4+ T lymphocytes. , 1999, Journal of immunology.
[18] N. Kadowaki,et al. Reciprocal control of T helper cell and dendritic cell differentiation. , 1999, Science.
[19] G. Schuler,et al. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. , 1999, Journal of immunological methods.
[20] K. Ariizumi,et al. T cell-mediated terminal maturation of dendritic cells. , 1997, Advances in experimental medicine and biology.
[21] Nina Bhardwaj,et al. Consequences of cell death: exposure to necrotic tumor cells , 2000 .
[22] R. de Waal Malefyt,et al. In contrast to their murine counterparts, normal human keratinocytes and human epidermoid cell lines A431 and HaCaT fail to express IL‐10 mRNA and protein , 1997, Clinical and experimental immunology.
[23] Wei Wu,et al. Identification and functional characterization of a second chain of the interleukin‐10 receptor complex , 1997, The EMBO journal.
[24] A. Iwasaki,et al. Freshly Isolated Peyer's Patch, but Not Spleen, Dendritic Cells Produce Interleukin 10 and Induce the Differentiation of T Helper Type 2 Cells , 1999, The Journal of experimental medicine.
[25] A. Giannetti,et al. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin. , 1997, The Journal of clinical investigation.
[26] F. Eko,et al. Suppression of Endogenous IL-10 Gene Expression in Dendritic Cells Enhances Antigen Presentation for Specific Th1 Induction: Potential for Cellular Vaccine Development1 , 2000, The Journal of Immunology.
[27] B. Kelsall,et al. Selective Suppression of IL-12 Production by Chemoattractants , 2000, The Journal of Immunology.
[28] P. Ricciardi-Castagnoli,et al. Differential effects of corticosteroids during different stages of dendritic cell maturation , 2000, European journal of immunology.
[29] R. Thomas,et al. Resistance of rheumatoid synovial dendritic cells to the immunosuppressive effects of IL-10. , 1999, Journal of immunology.
[30] P. Allavena,et al. The role of chemokines in the regulation of dendritic cell trafficking , 1999, Journal of leukocyte biology.
[31] P. Allavena,et al. Glucocorticoids affect human dendritic cell differentiation and maturation. , 1999, Journal of immunology.
[32] Liangji Zhou,et al. A distinct pattern of cytokine gene expression by human CD83+ blood dendritic cells. , 1995, Blood.
[33] P. Kalinski,et al. Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: the levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation. , 1998, Journal of immunology.
[34] A. Régnault,et al. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. , 1999, Journal of immunology.
[35] C. Albanesi,et al. Cross-linking of membrane CD43 mediates dendritic cell maturation. , 1999, Journal of immunology.
[36] A. Enk,et al. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. , 1993, Journal of immunology.
[37] M. Bukrinsky,et al. Lipopolysaccharide Inhibits HIV-1 Infection of Monocyte- Derived Macrophages Through Direct and Sustained Down-Regulation of CC Chemokine Receptor 51 , 2000, The Journal of Immunology.
[38] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[39] J. Banchereau,et al. Activation of human dendritic cells through CD40 cross-linking , 1994, The Journal of experimental medicine.
[40] C. Albanesi,et al. Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. , 2000, The Journal of investigative dermatology.
[41] M. Roncarolo,et al. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. , 1999, Journal of immunology.
[42] Yong‐jun Liu,et al. Anti–Interleukin 10 Receptor Monoclonal Antibody Is an Adjuvant for T Helper Cell Type 1 Responses to Soluble Antigen Only in the Presence of Lipopolysaccharide , 2000, The Journal of experimental medicine.
[43] A. Yoshimura,et al. Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation. , 1999, Blood.
[44] Hervé Groux,et al. A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.
[45] C G Figdor,et al. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.
[46] C. Caux,et al. Respective involvement of TGF‐β and IL‐4 in the development of Langerhans cells and non‐Langerhans dendritic cells from CD34+ progenitors , 1999, Journal of leukocyte biology.
[47] P. Kalinski,et al. Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. , 1999, Journal of immunology.
[48] J. Banchereau,et al. Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. , 1994, International immunology.
[49] Barbara Bottazzi,et al. Autocrine Production of IL-10 Mediates Defective IL-12 Production and NF-κB Activation in Tumor-Associated Macrophages1 , 2000, The Journal of Immunology.
[50] Stefania Gallucci,et al. Natural adjuvants: Endogenous activators of dendritic cells , 1999, Nature Medicine.
[51] K. Winestock,et al. IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. , 1995, Journal of immunology.
[52] Y. Liu,et al. IL‐10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3‐dependent and ‐independent pathways , 1998, The EMBO journal.
[53] F. Sallusto,et al. Mobilizing Dendritic Cells for Tolerance, Priming, and Chronic Inflammation , 1999, The Journal of experimental medicine.
[54] J. Simon,et al. Freshly isolated spleen dendritic cells and epidermal Langerhans cells undergo similar phenotypic and functional changes during short-term culture. , 1990, Journal of immunology.
[55] M. Moser,et al. Effect of interleukin‐10 on dendritic cell maturation and function , 1997, European journal of immunology.
[56] L. Adorini,et al. 1α,25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation , 2000, The Journal of Immunology.